Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.9 USD | -0.20% |
|
+1.80% | +30.09% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.09% | 2.25B | |
-6.61% | 12.02B | |
-19.37% | 6.81B | |
+6.63% | 5.74B | |
+27.24% | 5.47B | |
-21.19% | 3.59B | |
+6.64% | 2.56B | |
-66.53% | 2.24B | |
-12.28% | 2.21B | |
-21.64% | 1.52B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- (MYGN) MYRIAD GENETICS Forecasts 2024 Revenue Range $820M - $840M